Patent Assignment
Reel/Frame 048664/0789
Assignment of Assignor's Interest
Recorded: 2019-03-21
Pages: 6
Assignor
ALEXION PHARMACEUTICALS, INC.
Executed: 2019-03-07
Assignee
ORIGIN BIOSCIENCES, INC.
421 KIPLING STREET, PALO ALTO, CALIFORNIA, 94301
Covered Property
(1)
Method for Obtaining Precursor Z and Use Thereof for the Production of a Means for Therapy of Human Molybdenum Cofactor Deficiency
Related Assignments
(11)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 13, 2006
From: SCHWARZ, GUENTER; MENDEL, RALF; SANTAMARIA, JOSE; REISS, JOCHEN
To: TECHNISCHE UNIVERSITAT BRAUNSCHWEIG
Reel/Frame 018624/0800 →
Assignment of Assignor's Interest
Feb 18, 2011
From: THE TECHNICAL UNIVERSITY OF BRAUNSCHWEIG
To: ORPHATEC PHARMACEUTICALS GMBH
Reel/Frame 025837/0873 →
Assignment of Assignor's Interest
Feb 18, 2011
From: ORPHATEC PHARMACEUTICALS GMBH
To: ALEXION PHARMA INTERNATIONAL SARL
Reel/Frame 025836/0001 →
Change of Name
Feb 7, 2019
From: ALEXION PHARMA INTERNATIONAL SARL
To: ALEXION PHARMA GMBH
Reel/Frame 048284/0665 →
Assignment of Assignor's Interest
Feb 8, 2019
From: ALEXION PHARMA GMBH
To: ALEXION PHARMA HOLDING UNLIMITED COMPANY
Reel/Frame 048280/0369 →
Assignment of Assignor's Interest
Feb 11, 2019
From: ALEXION PHARMA HOLDING UNLIMITED COMPANY
To: ALEXION PHARMACEUTICALS, INC.
Reel/Frame 048292/0722 →
Corrective Assignment to Correct the Execution Date Previously Recorded at Reel: 25836 Frame: 001. Assignor(S) Hereby Confirms the Assignment.
Mar 30, 2021
From: ORPHATEC PHARMACEUTICALS GMBH
To: ALEXION PHARMA INTERNATIONAL SARL
Reel/Frame 055851/0383 →
Security Interest
Nov 17, 2021
From: BRIDGEBIO PHARMA, INC.; ORIGIN BIOSCIENCES, INC.; EIDOS THERAPEUTICS, INC.; QED THERAPEUTICS, INC.
To: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 058144/0302 →
Release of Security Interest
Apr 12, 2022
From: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: ORIGIN BIOSCIENCES, INC.
Reel/Frame 059577/0483 →
Assignment of Assignor's Interest
Apr 21, 2022
From: ORIGIN BIOSCIENCES, INC.
To: SENTYNL THERAPEUTICS, INC.
Reel/Frame 059671/0674 →
Release of Security Interest
Jan 18, 2024
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS SUCCESSOR TO U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: BRIDGEBIO PHARMA, INC.; ORIGIN BIOSCIENCES, INC.; EIDOS THERAPEUTICS, INC.; QED THERAPEUTICS, INC.
Reel/Frame 066167/0462 →